Cereno Scientific has secured a total of SEK 100 million through loan financing agreements. The financing consists of a new loan of SEK 25 million from Venusat ApS and SAJ Finance ApS, early payment of SEK 50 million from Fenja Capital II A/S and Arena Investors, and conversion of SEK 25 million in outstanding convertibles into B shares. The capital will be used to conduct a phase IIb study for CS1, initiate phase II program for CS014 and strengthen the company's partnership activities.
|
Published June 23, 2025
Cereno Scientific secures SEK 100 million in financing
Notes
Johnson & Johnson acquires Halda Therapeutics for $3 billion
Magle Group submits application for EmboCept S
Quia Pharma is delisted from Nasdaq
Stenocare acquires CannGros
Lundbeck enters the fight for Avadel
Klaria's partner CNX starts production of migraine film
Sofinnova Partners raises EUR 650 million in new fund
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account